RFK Jr. cancels $500M in mRNA vaccine funding

Robert F. Kennedy Jr. has reportedly influenced the US government's decision to withdraw $500 million in funding for mRNA vaccine research, claiming the technology poses "more risk than benefit." This move signals a shift in priorities and raises questions about the future of mRNA-based medical innovations.

Robert F. Kennedy Jr. has announced the cancellation of $500 million in funding for vaccine development, specifically targeting mRNA vaccines. In a video statement, he criticized the technology and halted projects involving major pharmaceutical companies.

Public health experts are expressing concern after the Trump administration, led by RFK Jr., cut roughly $500 million in funding for mRNA vaccine research. This decision could delay advancements in using the technology to combat future pandemics or treat diseases, according to specialists.

The US is pulling $500 million in funding for mRNA vaccines targeting diseases like flu and COVID-19, a decision linked to Robert F. Kennedy Jr.'s influence. Health correspondent James Gallagher questions whether this move is a smart public health strategy or a risky mistake.

Robert F. Kennedy Jr. has canceled contracts worth nearly $500 million related to mRNA vaccines, signaling a major shift in his organization's stance or strategy regarding these vaccines. The move could have significant financial and political implications, especially given Kennedy's vocal criticism of vaccine mandates and mRNA technology.

Robert F. Kennedy Jr.'s administration is cutting $500 million in funding for vaccine development, specifically targeting contracts for respiratory virus vaccines like COVID-19 and the flu. The Department of Health and Human Services is canceling these contracts, which could slow down or halt progress on these vaccines.

The U.S. Department of Health and Human Services (HHS) is canceling contracts and cutting $500 million in funding for mRNA vaccine development targeting respiratory viruses like COVID-19 and the flu, following pressure from RFK Jr. and other critics. This move halts progress on some vaccine research efforts.

The Trump administration, under Health and Human Services Secretary Robert F. Kennedy Jr., is canceling 22 contracts worth $500 million that were aimed at developing mRNA vaccines. Additionally, the government is scaling back further federal funding for mRNA technology.

The U.S. Department of Health and Human Services (HHS) is scaling back its mRNA vaccine development efforts under its Biomedical Advanced Research and Development Authority (BARDA), signaling a shift in priorities or strategy for government-backed vaccine research.